News

Liliya Mukhametzyanova was awarded the Commerzbank Foundation's Dr Walter Seipp Prize for her dissertation on ‘Increasing the utility of evolved site-specific recombinases for genome editing’. With this award, the foundation honours Liliya's excellent research work.

We are excited to share that SaxoCell has been chosen by the Federal Ministry of Education and Research (BMBF) and an independent expert panel to receive funding for a second phase in the Clusters4Future initiative.

We are delighted to announce a Reinhart Koselleck project in our research group! As part of its Reinhart Koselleck Programme, the German Research Foundation (DFG) has awarded Prof. Frank Buchholz a 1.25-million-euro research project.

Frank Buchholz and members of his research group attended the 30th Annual Meeting of the German Society for Gene Therapy (DG-GT), titled 'Nucleic Acid Therapeutics: Genetic Indications and Beyond' held in Munich, March 6-8.

Our new Nature Biotechnology paper "Activation of recombinases at specific DNA loci by zinc-finger domain insertions” has just been published!

Newspaper “Wirtschaftswoche” votes Seamless Therapeutics as “Start-up of the week”.

In our latest news release, Frank Buchholz (TU Dresden) and Anne-Kristin Heninger (Seamless Therapeutics GmbH) look at how designer recombinases have become a strong competitor of CRISPR. Explaining their research, Frank and Anne also reflect on the enormous potential of designer recombinases.